血管周围脂肪组织炎性反应促进动脉粥样硬化作用机制的研究进展

doi:10.16352/j.issn.1001-6325.2023.04.0685

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (4): 685-689.doi: 10.16352/j.issn.1001-6325.2023.04.0685

血管周围脂肪组织炎性反应促进动脉粥样硬化作用机制的研究进展

杜丰禾^1,2, 刘暴^1*

1.中国医学科学院北京协和医学院北京协和医院血管外科,北京 100730;
2.北京协和医学院临床医学专业试点班,北京 100730

收稿日期:2022-12-08 修回日期:2023-02-16 出版日期:2023-04-05 发布日期:2023-04-03
通讯作者: ^*liubao72@aliyun.com
基金资助:
国家自然科学基金(82070498,82100521);大学生创新训练计划项目(2022zglc06067);中央高水平医院临床科研业务费(2022-PUMCH-A-078,2022-PUMCH-A-189,2022-PUMCH-B-125);中国医学科学院中央级公益性科研院所基本科研业务费(2022-JKCS-09)

Research progress on the mechanism of perivascular adipose tissue inflammation promoting atherosclerosis

DU Fenghe^1,2, LIU Bao^1*

1. Department of Vascular Surgery, Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100730;
2. 4+4 Medical Doctor Program, PUMC, Beijing 100730,China

Received:2022-12-08 Revised:2023-02-16 Online:2023-04-05 Published:2023-04-03
Contact: ^*liubao72@aliyun.com

摘要/Abstract

摘要： 动脉粥样硬化严重威胁人类生命与健康。高血压、高脂血症病理条件下,血管周围脂肪组织(PVAT)中免疫细胞亚型紊乱、棕色脂肪“白色化”、氧化应激反应等病理改变可促进PVAT炎性反应。PVAT炎性反应可通过引起促炎及抑炎性脂肪因子分泌紊乱、抑制PVAT中细胞自噬、诱导动脉外膜滋养血管形成等机制,促进内皮细胞功能损害、动脉内膜单核-巨噬细胞浸润、动脉粥样硬化斑块形成、易损斑块形成等病理过程,从而促进动脉粥样硬化起病及进展。

关键词: 动脉粥样硬化, 血管周围脂肪组织, 心血管疾病, 基础研究, 临床应用

Abstract: Atherosclerosis is harmful to human health. Under pathological conditions including hypertension and hyperlipidemia, increased levels of pro-inflammatory immunocytes in perivascular adipose tissue (PVAT), “whitening” of brown adipose tissue, and oxidative stress could promote the development of PVAT inflammation. PVAT inflammation could induce various crucial stages of atherosclerosis by disturbing secretion of inflammatory and anti-inflammatory adipokines, inhibiting PVAT cell autophagy, and activating angiogenesis in arterial adventitia, thereby promoting the onset and progression of atherosclerosis.

Key words: atherosclerosis, perivascular adipose tissue, cardiovascular disease, basic research, clinical application

中图分类号:

R543.5

杜丰禾, 刘暴. 血管周围脂肪组织炎性反应促进动脉粥样硬化作用机制的研究进展[J]. 基础医学与临床, 2023, 43(4): 685-689.

DU Fenghe, LIU Bao. Research progress on the mechanism of perivascular adipose tissue inflammation promoting atherosclerosis[J]. Basic & Clinical Medicine, 2023, 43(4): 685-689.

参考文献

[1]Saxton SN, Withers SB, Heagerty AM. Perivascular adipose tissue anticontractile function is mediated by both endothelial and neuronal nitric oxide synthase isoforms[J]. J Vasc Res, 2022, 59:288-302.
[2]Watts SW, Flood ED, Garver H, et al. A new function for perivascular adipose tissue (PVAT): assistance of arterial stress relaxation[J]. Sci Rep, 2020, 10:1807. doi: 10.1038/s41598-020-58368-x.
[3]Kumar RK, Yang Y, Contreras AG, et al. Phenotypic changes in T cell and macrophage subtypes in perivasuclar adipose tissue precede high-fat diet-induced hypertension [J]. Front Physiol, 2021, 12:616055. doi: 10.3389/fphys.2021.616055.
[4]Wang J, Polaki V, Chen S, et al. Exercise improves endethelial function associated with alleviated inflammation and oxidative stress of perivascular adipose tissue in type 2 diabetic mice[J]. Oxid Med Cell Longev, 2020, 2020:8830537. doi: 10.1155/2020/8830537.
[5]Adachi Y, Ueda K, Nomura S, et al. Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling[J]. Nat Commun, 2022, 13:5117. doi: 10.1038/s41467-022-32658-6.
[6]Skiba DS, Nosalski R, Mikolajczyk TP, et al. Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis[J]. Br J Pharmacol, 2017, 174:4055-4069.
[7]Gu P, Hui X, Zheng Q, et al. Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome-dependent interleukin-1β production[J]. Sci Adv, 2021, 7:eabl4024. doi: 10.1126/sciadv.abl4024.
[8]Chen X, Huang Q, Feng J, et al. GLP-1 alleviates NLRP3 inflammasome-dependent inflammation in perivascular adipose tissue by inhibiting the NF-κB signalling pathway[J]. J Int Med Res, 2021, 49:300060521992981. doi: 10.1177/0300060521992981.
[9]Zhu B, Li Y, Mei W,et al. Alogliptin improves endothelial function by promoting autophagy in perivascular adipose tissue of obese mice through a GLP-1-dependent mechanism[J]. Vascul Pharmacol, 2019, 115:55-63.
[10]Pan XX, Yao KL, Yang YF, et al. Senescent T cell induces brown adipose tissue “whitening” via secreting IFN-γ[J]. Front Cell Dev Biol, 2021, 637424. doi: 10.3389/fcell.2021.637424.
[11]Sasoh T, Kugo H, Kondo Y,et al. Different effects of high-fat and high-sucrose diets on the physiology of perivascular adipose tissues of the thoracic and abdominal aorta[J]. Adipocyte, 2021, 10:412-423.
[12]Boucher JM, Ryzhova L, Harrington A,et al. Pathological conversion of mouse perivascular adipose tissue by Notch activation[J]. Arterioscler Thromb Vasc Biol, 2020, 40:2227-2243.
[13]Yang X, Liu Q, Li Y, et al. Inhibition of the sodium-glucose co-transporter SGLT2 by canagliflozin ameliorates diet-induced obesity by increasing intra-adipose sympathetic innervation [J]. Br J Pharmacol, 2021, 178:1756-1771.
[14]Mori K, Tsuchiya K, Nakamura S, et al. Ipragliflozin-induced adipose expansion inhibits cuff-induced vascular remodeling in mice[J]. Cardiovasc Diabetol, 2019, 18:83. doi: 10.1186/s12933-019-0886-1.
[15]Kroon T, Harms M, Maurer S,et al. PPARγ and PPARα synergize to induce robust browning of white fat in vivo[J]. Mol Metab, 2020, 36:100964. doi: 10.1016/j.molmet.2020.02.007.
[16]Mohd Idrus FN, Ahmad NS, Hoe CH,et al. Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients[J]. BMC Immunol, 2021, 22:21. doi: 10.1186/s12865-021-00410-2.
[17]Cheng WL, Zhang Q, Li B,et al. PAK1 silencing attenuated proinflammatory macrophage activation and foam cell formation by increasing PPARγ expression[J]. Oxid Med Cell Longev, 2021, 2021:6957900. doi: 10.1155/2021/6957900.
[18]Mu W, Qian S, Song Y,et al. BMP4-mediated browning of perivascular adipose tissue governs an anti-inflammatory program and prevents atherosclerosis[J]. Redox Biol, 2021, 43:101979. doi: 10.1016/j.redox.2021.101979.
[19]Mazzotta C, Basu S, Gower AC, et al. Perivascular adipose tissue inflammation in ischemic heart disease[J]. Arterioscler Thromb Vasc Biol, 2021, 41:1239-1250.
[20]Zhu X, Zhang HW, Chen HN,et al. Perivascular adipose tissue dysfunction aggravates adventitial remodeling in obese mini pigs via NLRP3 inflammasome/IL-1 signaling pathway[J]. Acta Pharmacol Sin, 2019, 40:46-54.
[21]Hettwer J, Hinterdobler J, Miritsch B,et al. Interleukin-1β suppression dampens inflammatory leucocyte produc-tion and uptake in atherosclerosis[J]. Cardiovasc Res, 2022, 118:2778-2791.
[22]Manka D, Chatterjee TK, Stoll LL,et al. Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1[J]. Arterioscler Thromb Vasc Biol, 2014, 34:1723-1730.
[23]Ito H, Wakatsuki T, Yamaguchi K, et al. Atherosclerotic coronary plaque is associated with adventitial vasa vasorum and local inflammation in adjacent epicardial adipose tissue in fresh cadavers[J]. Circ J, 2020, 84:769-775.
[24]Oikonomou EK, Antonopoulos AS, Schottlander D,et al. Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical device[J]. Cardiovasc Res, 2021, 117:2677-2690.
[25]Lee SE, Sung JM, Andreini D,et al. Association between changes in perivascular adipose tissue density and plaque progression[J]. JACC: Cardiovasc Imaging, 2022, 15:1760-1767.

血管周围脂肪组织炎性反应促进动脉粥样硬化作用机制的研究进展

Research progress on the mechanism of perivascular adipose tissue inflammation promoting atherosclerosis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	朱冰, 王旭. 斑点追踪成像技术在缺血性心脏病诊断中的应用[J]. 基础医学与临床, 2022, 42(9): 1459-1463.
[2]	刘珍竹, 李靖, 何丹, 曲鹏. PI3K信号通路调控动脉粥样硬化发生发展的研究进展[J]. 基础医学与临床, 2022, 42(9): 1428-1432.
[3]	赵茂宇, 李佑美, 刘焕云, 毛琦. 胰岛素抵抗标志物在动脉粥样硬化发病中的研究进展[J]. 基础医学与临床, 2022, 42(8): 1302-1305.
[4]	马茜钰, 彭石, 张兆元, 张丹, 张锦. 盐皮质激素受体对心血管疾病影响的研究进展[J]. 基础医学与临床, 2022, 42(8): 1292-1296.
[5]	谢思安, 徐俊玄, 宁婷婷, 张楠, 朱圣韬, 刘思. VAV1是动脉粥样硬化预后的潜在靶点和生物标志物[J]. 基础医学与临床, 2022, 42(7): 1092-1098.
[6]	朱李茹, 黄友明, 章宏祥, 周发友, 唐晓磊. 葡聚糖结合蛋白的原核表达及检测深部真菌感染的应用[J]. 基础医学与临床, 2022, 42(6): 883-889.
[7]	胡诗琪, 蓝彦琦, 吴寿岭, 王晓墨, 陈朔华, 汪国栋, 王丽. 肥胖及其变化对中国华北新发NAFLD成年男性患者心血管疾病发病风险的影响[J]. 基础医学与临床, 2022, 42(5): 788-794.
[8]	梁清, 陈丽红. 生物钟紊乱致心脏功能障碍的研究进展[J]. 基础医学与临床, 2022, 42(5): 799-803.
[9]	裘耀扬, 桂家辉, 黄林, 虎学强, 李勤. 血管内光学相干层析成像技术在冠状动脉粥样硬化斑块检测方面的应用[J]. 基础医学与临床, 2022, 42(3): 360-365.
[10]	张爽, 李之凡, 钱杰, 吴娜琼. 腔内影像学方法评价降脂治疗对冠状动脉粥样硬化斑块影响的研究进展[J]. 基础医学与临床, 2022, 42(3): 366-371.
[11]	张琦悦, 张伟丽. 血管老化在动脉粥样硬化中的研究进展[J]. 基础医学与临床, 2022, 42(3): 372-377.
[12]	赵川榕, 周菁. 靶向剪切力敏感关键分子的动脉粥样硬化防治研究[J]. 基础医学与临床, 2022, 42(3): 378-383.
[13]	李欢欢, 张玉齐, 吕海宏. 氧化应激增加多囊卵巢综合征患者心血管疾病风险的研究进展[J]. 基础医学与临床, 2022, 42(12): 1950-1954.
[14]	邹兴龙, 陈柱先, 孙娟娟, 蔡江滢, 苏露, 马薇, 傅思武. 壳聚糖药用制剂及其应用的研究进展[J]. 基础医学与临床, 2022, 42(11): 1791-1794.
[15]	吴岳恒, 余细勇. 人工智能在心血管疾病研究和临床中的应用[J]. 基础医学与临床, 2022, 42(11): 1644-1649.